↓ Skip to main content

Dove Medical Press

Efficacy and safety outcomes of sofosbuvir-based treatment regimens for hepatitis C virus-infected patients with or without cirrhosis from phase III clinical trials

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
37 Mendeley
Title
Efficacy and safety outcomes of sofosbuvir-based treatment regimens for hepatitis C virus-infected patients with or without cirrhosis from phase III clinical trials
Published in
Therapeutics and Clinical Risk Management, April 2017
DOI 10.2147/tcrm.s134818
Pubmed ID
Authors

Young-Mo Yang, Eun Joo Choi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 14%
Student > Ph. D. Student 5 14%
Researcher 4 11%
Student > Master 3 8%
Student > Bachelor 2 5%
Other 7 19%
Unknown 11 30%
Readers by discipline Count As %
Medicine and Dentistry 15 41%
Immunology and Microbiology 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Chemical Engineering 1 3%
Nursing and Health Professions 1 3%
Other 0 0%
Unknown 15 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2022.
All research outputs
#8,537,346
of 25,382,440 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#127,602
of 323,961 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#8
of 24 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,961 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.